Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16722640rdf:typepubmed:Citationlld:pubmed
pubmed-article:16722640lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:16722640lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:16722640lifeskim:mentionsumls-concept:C0034807lld:lifeskim
pubmed-article:16722640lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:16722640lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:16722640lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:16722640lifeskim:mentionsumls-concept:C0815278lld:lifeskim
pubmed-article:16722640pubmed:issue11lld:pubmed
pubmed-article:16722640pubmed:dateCreated2006-5-25lld:pubmed
pubmed-article:16722640pubmed:abstractTextA GABA(A) receptor study of several B-nor analogues of allopregnanolone and pregnanolone has been carried out. B-norallopregnanolone (i.e., 3alpha-hydroxy-7-nor-5alpha-pregnan-20-one) was found comparable to allopregnanolone when measured with labeled TBPS. Analogous results were obtained from their effect on neurons in culture: this time, both 3alpha-hydroxy-7-nor-5xi-pregnan-20-ones (5 and 6) were found to stimulate [3H]flunitrazepam binding and GABA-induced 36Cl- influx. These effects were inhibited by GABA(A) receptor antagonists. Other analogues carrying electronegative substituents (epoxides 9 and 10 and ketone 12) in the B ring were inactive. Similarly, B-normal ketones 17, and 18 and 6-azasteroids 20 and 21 were also inactive. B-Nor analogues 5 and 6 did not induce neurotoxicity at relevant concentrations. A computational analysis of active and inactive neurosteroid analogues allowed the proposal of a 3D pharmacophoric hypothesis of their interaction with the GABA(A) receptor.lld:pubmed
pubmed-article:16722640pubmed:languageenglld:pubmed
pubmed-article:16722640pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16722640pubmed:citationSubsetIMlld:pubmed
pubmed-article:16722640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16722640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16722640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16722640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16722640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16722640pubmed:statusMEDLINElld:pubmed
pubmed-article:16722640pubmed:monthJunlld:pubmed
pubmed-article:16722640pubmed:issn0022-2623lld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:KasalAlexande...lld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:GarcíaDaniel...lld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:SuñolCristina...lld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:BujonsJordiJlld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:BabotZoilaZlld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:KristofíkováZ...lld:pubmed
pubmed-article:16722640pubmed:authorpubmed-author:MatyásLiborLlld:pubmed
pubmed-article:16722640pubmed:issnTypePrintlld:pubmed
pubmed-article:16722640pubmed:day1lld:pubmed
pubmed-article:16722640pubmed:volume49lld:pubmed
pubmed-article:16722640pubmed:ownerNLMlld:pubmed
pubmed-article:16722640pubmed:authorsCompleteYlld:pubmed
pubmed-article:16722640pubmed:pagination3225-34lld:pubmed
pubmed-article:16722640pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:meshHeadingpubmed-meshheading:16722640...lld:pubmed
pubmed-article:16722640pubmed:year2006lld:pubmed
pubmed-article:16722640pubmed:articleTitleActivity of B-nor analogues of neurosteroids on the GABA(A) receptor in primary neuronal cultures.lld:pubmed
pubmed-article:16722640pubmed:affiliationInstitut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas, CSIC-IDIBAPS, Barcelona, Spain.lld:pubmed
pubmed-article:16722640pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16722640pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16722640lld:chembl